Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical indicators. Hence, the identification of new targeting molecules is crucial for an early detection and development of targeted therapies. This study aimed to identify and characterize novel peptides specific for the colorectal cancer cell line RKO using a phage-displayed peptide library. After four rounds of selection plus a negative step with normal colorectal cells, CCD-841-CoN, there was an obvious phage enrichment that specifically bound to RKO cells. Cell-based enzyme-linked immunosorbent assay (ELISA) was performed to assess the most specific peptides leading to the selection of the peptide sequence CPKSNNGVC. Through fluorescence micro...
Dissertação de mestrado integrado em Engenharia Biológica (área de especialização em Tecnologia Quím...
Genomic approaches are providing a wealth of information on differential gene expression in cancer. ...
Hepatocellular carcinoma is the fourth leading cause of cancer death worldwide. Novel treatment stra...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
AbstractColorectal cancer is the third most common malignancy in the United States. Improved detecti...
Tumor-targeting therapy can be an efficacious way to cure a malignant tumor in clinical trials. Phag...
AbstractColorectal cancer is the third most common malignancy in the United States. Improved detecti...
Colorectal cancer is the third most common malignancy in the United States. Improved detection sensi...
There is an urgent need for novel diagnostic methods capable of non-invasive, sensitive and feasible...
Colorectal cancer is the third most common malig-nancy in the United States. Improved detection sens...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
Dissertação de mestrado integrado em Engenharia Biológica (área de especialização em Tecnologia Quím...
Genomic approaches are providing a wealth of information on differential gene expression in cancer. ...
Hepatocellular carcinoma is the fourth leading cause of cancer death worldwide. Novel treatment stra...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
AbstractColorectal cancer is the third most common malignancy in the United States. Improved detecti...
Tumor-targeting therapy can be an efficacious way to cure a malignant tumor in clinical trials. Phag...
AbstractColorectal cancer is the third most common malignancy in the United States. Improved detecti...
Colorectal cancer is the third most common malignancy in the United States. Improved detection sensi...
There is an urgent need for novel diagnostic methods capable of non-invasive, sensitive and feasible...
Colorectal cancer is the third most common malig-nancy in the United States. Improved detection sens...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
Dissertação de mestrado integrado em Engenharia Biológica (área de especialização em Tecnologia Quím...
Genomic approaches are providing a wealth of information on differential gene expression in cancer. ...
Hepatocellular carcinoma is the fourth leading cause of cancer death worldwide. Novel treatment stra...